Pulmonary drug delivery systems for tuberculosis treatment.
about
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles.Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study.The Activity of a Hexameric M17 Metallo-Aminopeptidase Is Associated With Survival of Mycobacterium tuberculosis.The anti-tuberculosis agents under development and the challenges ahead.Lessons from black pepper: piperine and derivatives thereof.The long and winding road to inhaled TB therapy: not only the bug's fault.Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.Inhalable Antitubercular Therapy Mediated by Locust Bean Gum Microparticles.Electrostatically entrapped colistin liposomes for the treatment of Pseudomonas aeruginosa infection.Effects of the encapsulation of usnic acid into liposomes and interactions with antituberculous agents against multidrug-resistant tuberculosis clinical isolates.Preparation, characterization, and in vitro evaluation of isoniazid and rifampicin-loaded archaeosomes.Drug delivery for tuberculosis: is inhaled therapy the key to success?Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment.The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases.Iron-Based Metal-Organic Frameworks as a Theranostic Carrier for Local Tuberculosis Therapy.In vitro performances of novel co-spray-dried azithromycin/rifampicin microparticles for Rhodococcus equi disease treatmentSpray Drying Strategies to Stop Tuberculosis
P2860
Q33905993-ABACE601-097E-4F03-A1C8-D41BCDFCE394Q35950533-257FED8C-913D-49C0-A434-CD331E36F330Q37721237-EFA55B59-D80E-4FD6-ABDB-122B90511A21Q38617197-ACB428EA-81A8-4D1C-B3E7-9AB56B028607Q38631441-CAA71D69-A4EB-4E18-8DE8-044A4938AD68Q38782463-1371D832-0D98-4A75-AAC9-AD172D37B50DQ38967890-45E2CB0D-8B79-4F79-A114-927B55666A94Q39725802-F9D69428-89A1-42E5-95F2-30E69029DCB4Q40558076-E44E6B81-46D9-4873-AE21-985F204245A8Q40688651-FF09FC0A-77EF-4981-BAAB-7CA49887C0CDQ43031247-2A92C802-25A5-4B19-81B6-FDB59B3C18BCQ47763488-1F1ADAE7-8DA4-4496-A3C5-362C08F9EF70Q50074735-B07955FD-ED80-4475-BAA7-B8DF3FFCE377Q50124824-12B50AB3-2B4A-4BD0-B6C9-3CDBE2064F25Q55278388-ABEB5892-9D4B-4600-A4B0-C2C2BA63EF10Q56557702-2CCBE0E4-AA4D-4E8C-9C60-BDAE168D151EQ59291746-937B4361-8723-4FC9-B5D3-22B5BD84D8EA
P2860
Pulmonary drug delivery systems for tuberculosis treatment.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Pulmonary drug delivery systems for tuberculosis treatment.
@en
type
label
Pulmonary drug delivery systems for tuberculosis treatment.
@en
prefLabel
Pulmonary drug delivery systems for tuberculosis treatment.
@en
P1476
Pulmonary drug delivery systems for tuberculosis treatment.
@en
P2093
Dinh-Duy Pham
P304
P356
10.1016/J.IJPHARM.2014.12.009
P407
P577
2014-12-10T00:00:00Z